Статті в журналах з теми "Du er ping kuang"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-31 статей у журналах для дослідження на тему "Du er ping kuang".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Chi, Ya-Hui, Chun-Ping Chang, Teng-Kuang Yeh, Chiung-Tong Chen, Wan-Ping Wang, Yen-Ting Chen, Chia-Hua Tsai, et al. "Abstract 5806: Discovery of a long half-life AURKA inhibitor to treat MYC-amplified solid tumors as a monotherapy and in combination with everolimus." Cancer Research 84, no. 6_Supplement (March 22, 2024): 5806. http://dx.doi.org/10.1158/1538-7445.am2024-5806.
Повний текст джерелаChi, Ya-Hui, Chun-Ping Chang, Teng-Kuang Yeh, Wan-Ping Wang, Yen-Ting Chen, Chia-Hua Tsai, Yan-Fu Chen, et al. "Abstract 523: Targeting myc-amplified cancers with a novel prodrug inhibiting aurora A kinase." Cancer Research 83, no. 7_Supplement (April 4, 2023): 523. http://dx.doi.org/10.1158/1538-7445.am2023-523.
Повний текст джерелаBall, Alexander, Yung Lin Hsieh, Chun Kai Huang, Sega Huang, Ping Kuan Hsieh, Shang Ru Wu, Yue Yun Chang, Jiming Liu, Po Shin Peng, and Chia Yi Lin. "Abstract 1325: Novel recombinant rabbit monoclonal antibodies for cancer biology research." Cancer Research 83, no. 7_Supplement (April 4, 2023): 1325. http://dx.doi.org/10.1158/1538-7445.am2023-1325.
Повний текст джерелаLi, Ning, Peng Jiang, Yuzhen Huang, Yuan TU, Wei Kong, Shan Jiang, Jingni Zhang, et al. "Estrogen Receptor- And Progesterone Receptor-Positive Thresholds in Predicting the Recurrence of Early Low-Risk Endometrial Cancer." Clinical Medicine Insights: Oncology 16 (January 2022): 117955492211032. http://dx.doi.org/10.1177/11795549221103200.
Повний текст джерелаBondebjerg, Ib. "Kritisk teori, æstetik og receptionsforskning." MedieKultur: Journal of media and communication research 4, no. 7 (January 26, 1988): 26. http://dx.doi.org/10.7146/mediekultur.v4i7.765.
Повний текст джерелаHou, Sharon S. J., and Huang Wei-liang. "Huo-yu te feng-hung: Yu Kuang-chung tso-p'in p'ing-lun chi (Huo-yu de feng-huang)---(Yu Guang-zhong zuo pin ping-lun ji)." Chinese Literature: Essays, Articles, Reviews (CLEAR) 7, no. 1/2 (July 1985): 201. http://dx.doi.org/10.2307/495212.
Повний текст джерелаAgger, Gunhild. "Reklamen som pastiche. Om Dansk Sygeplejeråds annoncekampagne efteråret 1986." MedieKultur: Journal of media and communication research 5, no. 10 (March 27, 1989): 19. http://dx.doi.org/10.7146/mediekultur.v5i10.808.
Повний текст джерелаQuroturohman, Denis. "PENETRATION TESTING DALAM FORENSIK DIGITAL PADA JARINGAN FAKULTAS TEKNIK UNIVERSITAS IBN KHALDUN BOGOR DENGAN PING OF DEATH." Jurnal Inovatif : Inovasi Teknologi Informasi dan Informatika 4, no. 2 (November 3, 2021): 81. http://dx.doi.org/10.32832/inova-tif.v4i2.5812.
Повний текст джерелаWang, Ping, Mariam Hassan, and Anjan Chatterjee. "1493. The Incremental Burden of Nontuberculous Mycobacterial Lung Disease (NTMLD) among Patients with chronic obstructive pulmonary disease (COPD): Hospitalizations and ER Visits among US Medicare Beneficiaries." Open Forum Infectious Diseases 7, Supplement_1 (October 1, 2020): S748—S749. http://dx.doi.org/10.1093/ofid/ofaa439.1674.
Повний текст джерелаChen, Mei-Kuang, Grace DeAlessandro, Tuyen Bui, and Khandan Keyomarsi. "Abstract PO2-04-14: Dual Inhibition of WEE1 and PKMYT1 Synergistically Overcomes CDK4/6 Inhibitor Resistance in Breast Cancer." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO2–04–14—PO2–04–14. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-04-14.
Повний текст джерелаLee, Pony Yu-Ling, Marvin A. Aberin, Chien-Chang Shen, Kun-Yuan Lin, Chao Di Chang, Chih-Chieh Yang, Shan-Yun Cheng, Ya Wen Hung, Xin-Guo Hsu, and Shu-Ping Wang. "Abstract 5953: Reshaping the tumor microenvironment: new application of tamoxifen in triple negative breast cancer immunomodulation." Cancer Research 83, no. 7_Supplement (April 4, 2023): 5953. http://dx.doi.org/10.1158/1538-7445.am2023-5953.
Повний текст джерелаLi, Hui-Ping, Qingyuan Zhang, Ruyan Zhang, Yaxin Liu, and Xianjun Hu. "Abstract PO4-04-01: Antitumor activity and safety of sacibertinib (Hemay022) in combination with endocrine therapy in patients with ER and HER2 both positive metastatic breast cancer: A phase Ib study." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO4–04–01—PO4–04–01. http://dx.doi.org/10.1158/1538-7445.sabcs23-po4-04-01.
Повний текст джерелаSun, Yu, and Longhai Zhang. "Shakespeare across the Taiwan Strait: A Developmental Perspective." Multicultural Shakespeare: Translation, Appropriation and Performance 20, no. 35 (December 30, 2019): 115–31. http://dx.doi.org/10.18778/2083-8530.20.09.
Повний текст джерелаLi, Hui-Ping, Qingyuan Zhang, Ruyan Zhang, Yaxin Liu, Chang Liu, and Xianjun Hu. "Abstract PO2-27-11: Antitumor efficacy and safety of sacibertinib (Hemay022) in combination with endocrine therapy in patients with ER+ and HER2+ metastatic breast cancer: A phase Ib study." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO2–27–11—PO2–27–11. http://dx.doi.org/10.1158/1538-7445.sabcs23-po2-27-11.
Повний текст джерелаYu, Kun, Tenghui Chen, Manav Korpal, Ping Zhu, Zhaojie Zhang, Lihua Yu, and Yonghong Xiao. "Abstract 4123: Real-world data to identify the genomic association with response to CDK4/6i + Endocrine therapy in ER+ breast cancer patients." Cancer Research 82, no. 12_Supplement (June 15, 2022): 4123. http://dx.doi.org/10.1158/1538-7445.am2022-4123.
Повний текст джерелаLi, Hui-Ping, Guohong Song, Hanfang Jiang, Xu Liang, Xiaojia Wang, Hua Yang, Lili Zhang, and Youzhi Tong. "Abstract PS15-07: Proxalutamide plus Endocrine Therapies in Women with HR+/HER2-/AR+ Metastatic Breast Cancer: A Phase Ic Study." Cancer Research 84, no. 9_Supplement (May 2, 2024): PS15–07—PS15–07. http://dx.doi.org/10.1158/1538-7445.sabcs23-ps15-07.
Повний текст джерелаLu, Haizhen, Dong Kuang, Lili Jiang, Jingping Yun, Qingxin Xia, Jian Wang, Pei Duan, et al. "Abstract 5463: The PD-L1 protein expression in Chinese patients with recurrent or metastatic head and neck squamous cell carcinoma: A multi-center retrospective study." Cancer Research 83, no. 7_Supplement (April 4, 2023): 5463. http://dx.doi.org/10.1158/1538-7445.am2023-5463.
Повний текст джерелаZhao, Tianying, Shuai Xu, Jie Ping, Guochong Jia, Yongchao Dou, Bing Zhang, Xingyi Guo, et al. "Abstract 1716: A proteome-wide association study identifies putative causal proteins for breast cancer." Cancer Research 84, no. 6_Supplement (March 22, 2024): 1716. http://dx.doi.org/10.1158/1538-7445.am2024-1716.
Повний текст джерелаWen, Kuang-Yi, Suzanne Miller, Aruna Padmanabhan, Rita Smith, Emmanuel Lapitan, and Lori Goldstein. "Abstract B119: Effect of a smart pill bottle and text messaging-based intervention on medication adherence and side effect management in African American women with breast cancer new to endocrine therapy." Cancer Epidemiology, Biomarkers & Prevention 32, no. 1_Supplement (January 1, 2023): B119. http://dx.doi.org/10.1158/1538-7755.disp22-b119.
Повний текст джерелаKubler, Kirsten, Agostina Nardone, Shankara Anand, Daniel Gorvich, Marjolein Droog, Francisco Hermida-Prado, Tara Akshi, et al. "Abstract GS2-09: Tamoxifen instigates uterine cancer development by activating PI3K signaling and supersedes PIK3CA driver mutations." Cancer Research 82, no. 4_Supplement (February 15, 2022): GS2–09—GS2–09. http://dx.doi.org/10.1158/1538-7445.sabcs21-gs2-09.
Повний текст джерелаJabado, Omar, Suzana Couto, Jordan Blum, Patrick Franken, Patricia Coutinho de Souza, Maria Jure-Kunkel, Nora Pencheva, Brandon Higgs, Kate Sasser, and Mark Fereshteh. "238 Molecular dissection of tumor-immune microenvironment factors associated with response to checkpoint inhibitor therapy in non-small cell lung cancer patients using nanostring digital spatial profiling." Journal for ImmunoTherapy of Cancer 8, Suppl 3 (November 2020): A255—A256. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0238.
Повний текст джерелаAberin, Marvin A., Yu-Ling (Pony) Lee, Xin-Guo Hsu, Chen-Yang Shen, Yao-Ming Chang, Kun-Yuan Lin, Chandan Guha, and Shu-Ping Wang. "Abstract 3646: New functional role of tamoxifen in breast cancer immunomodulation: role of RACK7 in activation of type I interferon signaling and CEACAM1/TIM-3-dependent immunosuppression." Cancer Research 83, no. 7_Supplement (April 4, 2023): 3646. http://dx.doi.org/10.1158/1538-7445.am2023-3646.
Повний текст джерелаHuang, Lisi, Xin Du, Jianyu Weng, Peilong Lai, Zesheng Lu, Ping Wu, Suijing Wu, Chengwei Luo, Xin Huang, and Suxia Geng. "Comparison of the 5 Year Medical Outcome and Quality of Life of Patients with Chronic Myeloid Leukemia Treated with Imatinib or Allogeneic Transplant." Blood 126, no. 23 (December 3, 2015): 2118. http://dx.doi.org/10.1182/blood.v126.23.2118.2118.
Повний текст джерелаLiang, Yuehua, Hui Ping Li, and Zehui Yun. "Abstract C035: Chemotherapy plus HER2-targeted therapy versus endocrine therapy plus HER2-targeted therapy as first-line treatment in patients with HR+/HER2+advanced breast cancer: A real-world trial." Molecular Cancer Therapeutics 22, no. 12_Supplement (December 1, 2023): C035. http://dx.doi.org/10.1158/1535-7163.targ-23-c035.
Повний текст джерелаPuca, Loredana, Michele S. Dowless, Carmen M. Perez-Ferreiro, Maria Jesus Ortiz-Ruiz, Gregory P. Donoho, Andrew Capen, Lysiane Huber та ін. "Abstract P4-08-02: LOXO-783: A potent, highly mutant selective and brain-penetrant allosteric PI3Kα H1047R inhibitor in combination with standard of care (SOC) treatments in preclinical PI3Kα H1047R-mutant breast cancer models". Cancer Research 83, № 5_Supplement (1 березня 2023): P4–08–02—P4–08–02. http://dx.doi.org/10.1158/1538-7445.sabcs22-p4-08-02.
Повний текст джерелаLuo, Ting, Xiaorong Zhong, Ping He, Dan Zheng, Yan Cheng, and Kunrui Zhu. "Abstract PO4-18-03: Combined Treatment with Pyrotinib and Chrysin Synergistically Improve the Autophagy Level in HER2-Positive Breast Cancer by Regulating the miR-16-5p/ZBTB16/G6PD Axis." Cancer Research 84, no. 9_Supplement (May 2, 2024): PO4–18–03—PO4–18–03. http://dx.doi.org/10.1158/1538-7445.sabcs23-po4-18-03.
Повний текст джерелаGrzegorczyk, Adrian, and Marcin Mamajek. "A 70 W thulium-doped all-fiber laser operating at 1940 nm." Photonics Letters of Poland 11, no. 3 (September 30, 2019): 81. http://dx.doi.org/10.4302/plp.v11i3.928.
Повний текст джерелаNielsen, Klaus Bo. "Xunzis ritualanalyse." Religionsvidenskabeligt Tidsskrift, no. 51 (February 29, 2008). http://dx.doi.org/10.7146/rt.v0i51.1715.
Повний текст джерелаPileberg, Silje. "Stabile tal for sjølvmord i Noreg." Suicidologi 25, no. 3 (January 25, 2021). http://dx.doi.org/10.5617/suicidologi.8543.
Повний текст джерелаYang, Fang, Yonghui Yu, and Hong Liu. "Mechanism of Action of Yikun Yitong Ping-Containing Serum on Mast Cells and its Possible Involvement in Endometriosis-Related Dysmenorrhea." Natural Product Communications 19, no. 2 (February 2024). http://dx.doi.org/10.1177/1934578x241229929.
Повний текст джерелаDung, Nguyen Thi, Hoang Van Thanh, and Nguyen Dinh Lam. "Influences of Growth Durations on Characteristics of NaYF4:(Yb,Tm) Upconversion Materials." VNU Journal of Science: Natural Sciences and Technology 35, no. 4 (December 23, 2019). http://dx.doi.org/10.25073/2588-1140/vnunst.4965.
Повний текст джерела